QUOTED. Dec. 19, 2018. William Maisel.
Executive Summary
The acting compliance office chief for US FDA's device center, William Maisel, was giddy about the growth and popularity of the Medical Device Single Audit Program during a recent Food & Drug Law Institute conference in Washington, DC. See what he said about MDSAP here.
“We believe MDSAP will and should grow. The key elements we’re thinking about are how to best share the information between governments, and how to use audit reports from participating authorities.” –William Maisel, acting compliance office director, US FDA
Click here for a free trial of Medtech Insight